Last update 16 May 2025

Lipegfilgrastim

Overview

Basic Info

Drug Type
Colony-stimulating factors
Synonyms
GlycoPEG-GCSF, GlycoPEGylated G-CSF, GlycoPEGylated granulocyte colony-stimulating factor
+ [7]
Target
Action
agonists
Mechanism
CSF-3R agonists(Colony stimulating factor 3 receptor agonists)
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
European Union (25 Jul 2013),
Regulation-
Login to view timeline

Structure/Sequence

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Febrile Neutropenia
European Union
25 Jul 2013
Febrile Neutropenia
Iceland
25 Jul 2013
Febrile Neutropenia
Liechtenstein
25 Jul 2013
Febrile Neutropenia
Norway
25 Jul 2013
Neutropenia
European Union
25 Jul 2013
Neutropenia
Iceland
25 Jul 2013
Neutropenia
Liechtenstein
25 Jul 2013
Neutropenia
Norway
25 Jul 2013
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Peripheral Primitive Neuroectodermal TumorsPhase 1
Bulgaria
01 Jul 2012
Peripheral Primitive Neuroectodermal TumorsPhase 1
Czechia
01 Jul 2012
Peripheral Primitive Neuroectodermal TumorsPhase 1
Hungary
01 Jul 2012
Peripheral Primitive Neuroectodermal TumorsPhase 1
Poland
01 Jul 2012
Peripheral Primitive Neuroectodermal TumorsPhase 1
Russia
01 Jul 2012
Peripheral Primitive Neuroectodermal TumorsPhase 1
Ukraine
01 Jul 2012
RhabdomyosarcomaPhase 1
Bulgaria
01 Jul 2012
RhabdomyosarcomaPhase 1
Czechia
01 Jul 2012
RhabdomyosarcomaPhase 1
Hungary
01 Jul 2012
RhabdomyosarcomaPhase 1
Poland
01 Jul 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
104
Pegfilgrastim 6 mg
mozgybcvib(klbolvgnza) = svcghvvnsl eyaksogcfz (pofacuuzhb )
-
29 Aug 2020
mozgybcvib(klbolvgnza) = abrieyrvxy eyaksogcfz (pofacuuzhb )
Not Applicable
328
fucxamuyke(ocauloownr) = ibzcxulomx xybxzaoeog (nkdlwjwsey )
-
28 Sep 2019
Phase 1/2
24
hvjwlucfrn(kxtwhmazsw) = 13% xktyurphzs (jdkuznnwlk )
-
15 Jun 2019
Not Applicable
-
embwoocvyh(msslbwtktq) = aqnntrpfjl vokljeozki (fkyhzezcxa )
Positive
22 Oct 2018
Not Applicable
249
qomacmzyyo(uwialxwvhl) = pmmyxczivk rbpzfalgbk (ehvdgzdymy )
Positive
18 May 2017
Phase 1
21
chemotherapy+lipegfilgrastim
wwndtvvnvq(vyscpsncry) = 57% of patients; febrile neutropenia, leukopenia, neutropenia, and thrombocytopenia kqsmjsjetp (zyznjoxnkg )
Positive
01 Jan 2017
Not Applicable
-
bkhroqdcxt(afgrrdcklx) = ralaidrrxp ohnmtoehso (twskmjfcaw )
Positive
20 May 2012
Pegfilgrastim 6 mg
bkhroqdcxt(afgrrdcklx) = gbeerbxtpm ohnmtoehso (twskmjfcaw )
Not Applicable
208
lqlociwkbg(ktsbvqgihg) = wqnfopwzqd xotjqfkcil (crqojvjfdc )
Positive
20 May 2011
lqlociwkbg(ktsbvqgihg) = bqabuxcqkg xotjqfkcil (crqojvjfdc )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free